A 77-yr-old woman presented to the hospital with cough and dyspnea. Two years ago, she was diagnosed with non-small cell lung cancer and had been treated with wedge resection and several rounds of combined chemotherapy and radiation therapy.
INTRODUCTION
Rhodotorula species are known as contaminants because of their omnipresence in the environment such as in the air, soil, lakes, and ocean water. Due to their ubiquitous and saprophytic nature, the isolation of Rhodotorula from nonsterile sites such as the skin, sputum, urine, and feces has often been of doubtful clinical significance. However, it has been considered as pathogen,
진행성 비소세포폐암 환자에서 발생한 Rhodotorula 패혈증 1예
Sepsis Due to Rhodotorula mucilaginosa in a Patient with Advanced Non-Small Cell Lung Cancer Aerobic cultures of blood samples drawn during the first episode of fever flagged positive 5 days after incubation; these were subcultured. The isolates gave rise to smooth, mucoid, glistening, pink to coral red colonies ( Fig. 1 ). Gram staining revealed globose and elongated budding yeasts without any pseudohyphae (Fig. 2 ).
The Vitek2 system (BioMerieux Inc., Hazelwood, USA) identified the isolated colonies as Rhodotorula glutinis/mucilaginosa (90% probability). Therefore, we performed molecular identification by sequencing the internal transcribed spacer (ITS) sequence of the ribosomal transcript. The ITS region was amplified using the primer sets ITS1 (5′-TCCGTAGGTGAACCTGCGG-3′) with ITS1-F (3′-CTTGGTCATTTAGAGGAAGTAA-5′) and ITS4 (5′-TCCTCC-GCTTATTGATATGC-3′) with ITS4-B (3′-CAGGAGACTTGTA-CACGGTCCAG-5′). The amplicons showed 98.85% similarity with the ITS region of R. mucilaginosa (NR_073296.1), confirming that the isolated fungus was R. mucilaginosa.
In addition, aerobic cultures of blood samples collected during the second episode of fever were also positive after 4 days of incubation, and the same microorganisms were identified. Antifungal susceptibility tests revealed that the isolate was susceptible to amphotericin B (minimum inhibitory concentration, MIC 0.5 μg/ mL) and voriconazole (MIC 1.0 μg/mL) and resistant to fluconazole (MIC 32 μg/mL), casopofungin (MIC >8 μg/mL), and micafungin (MIC >8 μg/mL).
DISCUSSION
Rhodotorula species are the fourth most common non-candida yeast isolated from clinical specimens (4.2% of 8,821 isolates) [4] .
The first case of Rhodotorula fungemia was reported in 1960 by
Louria et al. in a patient with endocarditis [5] . Since then, a number of Rhodotorula infections have been reported. Recent studies have showed that the incidence of Rhodotorula fungemia is from 0.5% to 2.3% in Europe [6] and USA [7] .
The major risk factors of Rhodotorula infection are prolonged use of central venous catheters in patients with a hematologic or solid malignancy, prolonged use of corticosteroids and/or cytotoxic drugs [7, 8] , and long-term used of broad-spectrum antibiotics [7] . The most prevalent species was R. mucilaginosa, formerly known as R. rubra, followed by R. glutinis. Our patient had been treated with cytotoxic agents eight times and broad-spectrum antibiotics daily for two months before admission, but no catheter was used.
Since Rhodotorula is not a common cause of infection, there are no definite treatment guidelines for Rhodotorula fungemia.
In many cases, patients have been treated effectively with removal of the indwelling catheter and/or appropriate antifungal agents [2, 3, 7] . One in vitro study revealed that Rhodotorula species were reliably susceptible to amphotericin and flucytosine, but resistant to fluconazole and echinocandin; and susceptibility to new triazoles such as itraconazole, voriconazole and posconazole is not predictable [9, 10] . The presumed mechanism of resistance to echinocandin is inhibition of access to the site of drug action in the fungal cell wall [11] . Although Rhodotorula species are less virulent than Candida and Cryptococcus species, the associated mortality rate was 12.6% in the largest systematic review [12] . In the current case, no catheter was inserted and only peripheral IV 
